Log in to save to my catalogue

Unveiling the comorbidity burden of male breast cancer

Unveiling the comorbidity burden of male breast cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e25dff9af1b94238ab04e8733eb186f9

Unveiling the comorbidity burden of male breast cancer

About this item

Full title

Unveiling the comorbidity burden of male breast cancer

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-10, Vol.14 (1), p.22977-14, Article 22977

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Male breast cancer (MBC) is a rare condition with unique characteristics compared to female breast cancer (FBC). Despite its scarceness, there is growing evidence that MBC should not be studied and treated as FBC due to factors like later diagnosis stage and distinct genetic makeup. Retrospective observational study in the EpiChron Cohort, selectin...

Alternative Titles

Full title

Unveiling the comorbidity burden of male breast cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e25dff9af1b94238ab04e8733eb186f9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e25dff9af1b94238ab04e8733eb186f9

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-73032-4

How to access this item